You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘heart failure’
March 2010
Br J Cardiol 2010;17:76–80
Recommendations on the clinical use of B-type natriuretic peptide testing (BNP or NTproBNP) in the UK and Ireland
Plasma natriuretic peptide (NP) testing is not widely used in heart failure clinical practice in the UK or Ireland, despite a large evidence base. This
November 2008
Br J Cardiol 2008;15: 322–5
Co-morbid psychiatric disorders among subjects in stable state of heart failure in a West African teaching hospital
Heart failure (HF) is an important cause of morbidity and mortality in the general hospital setting worldwide. The paucity of data on psychiatric co-morbidity in
September 2008
Br J Cardiol 2008;15:231-36
News from the 2008 Congress of the European Society of Cardiology
Highlights of the European Society of Cardiology meeting held in Munich, Germany, August 30th – September 3rd 2008 showed further benefit for fish oils, this
September 2008
Br J Cardiol 2008;15:261-5
Renal and cardiac arterial disease: parallels and pitfalls
Renal artery stenosis is a condition that has significant effects on the progression and outcomes of co-existent cardiac disease. The most important cause of renal
July 2008
Br J Cardiol 2008;15:179–80
Cost-effectiveness and use of natriuretic peptides in clinical practice – do we have enough evidence yet?
Clinicians find heart failure difficult to diagnose.1 Confirmation of left ventricular dysfunction (systolic or diastolic) is only possible by cardiac imaging. Recent European Society of
March 2008
Br J Cardiol 2008;15:101-5
A budget impact model for a drug in heart failure: eplerenone
The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) showed that addition of eplerenone to optimal medical therapy reduced morbidity and mortality
January 2008
Br J Cardiol 2008;15:6
Primary care heart failure services
There is a need to meet the demand, led by primary care, for the appropriate assessment and management of patients with heart failure. Standard 11
January 2008
Br J Cardiol 2008;15:35-9
Evaluation of an open-access heart failure service spanning primary and secondary care
Heart failure (HF) is common and the current gold-standard diagnostic modality for left ventricular systolic dysfunction (LVSD) is transthoracic echocardiography (TTE). To comply with the
November 2007
Br J Cardiol 2007;14:275-79
Improving access to financial support for heart failure patients: understanding the claims process and the doctors’ role
Many heart failure patients are eligible to receive financial support (Disability Living Allowance or Attendance Allowance) because of their impaired mobility. Those with a very